SormaniMPRioJTintorèM. Scoring treatment response in patients with relapsing multiple sclerosis. Mult Scler. [Epub ahead of print 25September2012. DOI: 10.1177/1352458512460605.
2.
PRISMS (Prevention of Relapses and disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. Lancet1998; 352: 1498–1504.